ANNX

Annexon, Inc.

5.86 USD
+0.29 (+5.21%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Annexon, Inc. stock is up 40.87% since 30 days ago. The next earnings date is Mar 12, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 March’s closed higher than February. In the last 2 Unusual Options Trades, there were 2 CALLs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
09 Feb 19:22 19 Jul, 2024 5.00 CALL 500 144
09 Feb 19:23 19 Jul, 2024 5.00 CALL 400 144

About Annexon, Inc.

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. Its product candidates include ANX005, a monoclonal antibody, which is in Phase II/III clinical trials to treat patients with guillain-baré syndrome. The company was incorporated in 2011 and is headquartered in Brisbane, California.